Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 58.28

+5.7%

2:38 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dr_elis who wrote (10856)	3/5/2004 8:59:02 AM
From: Biomaven	of 52153

price target for ELN? No, for two reasons: 1. My play is based on the relative valuations of BIIB and ELN. I'm assuming we'll get good continuing news flow from Anetegren and based on this ELN should improve relative to BIIB. 2. In general I don't use price targets. It's not sensible to look at an absolute price of a stock independent of what other biotechs (and indeed the broader market) are doing. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next